|
|
Name: |
MPM ONCOLOGY IMPACT MANAGEMENT LP |
City: |
CAMBRIDGE |
State: |
MA |
Zip: |
02142 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
53 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
CGEM |
Cullinan Oncology Ord Shs |
1 |
- |
$0.00 |
$57,897,000 |
7,648,268 |
9.95% |
-35,259,000 |
0 |
1.757 |
N/A |
|
MDGL |
Madrigal Pharmaceuticals Inc |
2 |
- |
$300.15 |
$33,260,000 |
100,415 |
5.72% |
33,260,000 |
100,415 |
0.391 |
Diagnostic Substances |
|
ZLAB |
Zai Lab Ltd |
3 |
- |
$35.49 |
$30,128,000 |
833,659 |
5.18% |
9,176,000 |
33,659 |
0.947 |
N/A |
|
EWTX |
Edgewise Therapeutics, Inc. |
4 |
- |
$13.01 |
$24,320,000 |
1,105,444 |
4.18% |
-4,498,000 |
26,128 |
1.072 |
N/A |
|
LNTH |
Lantheus Holdings, Inc. |
5 |
- |
$79.62 |
$22,681,000 |
232,387 |
3.9% |
1,549,000 |
-3,826 |
0.322 |
N/A |
|
PTCT |
PTC Therapeutics, Inc. |
6 |
- |
$49.15 |
$22,421,000 |
439,977 |
3.85% |
2,796,000 |
5,210 |
0.486 |
Biotechnology |
|
NTRA |
Natera, Inc. |
7 |
- |
$161.57 |
$22,208,000 |
157,047 |
3.82% |
-3,219,000 |
-3,579 |
0.127 |
N/A |
|
TRVI |
Trevi Therapeutics, Inc. |
8 |
- |
$0.00 |
$21,564,000 |
3,428,366 |
3.71% |
8,813,000 |
333,470 |
3.369 |
N/A |
|
CRNX |
Crinetics Pharmaceuticals, ... |
9 |
- |
$29.44 |
$21,196,000 |
631,964 |
3.64% |
-10,353,000 |
14,929 |
0.687 |
N/A |
|
RNA |
Avidity Biosciences, Inc. |
10 |
- |
$29.36 |
$21,084,000 |
714,224 |
3.62% |
641,000 |
11,243 |
0.529 |
N/A |
|
GH |
Guardant Health, Inc. |
11 |
- |
$0.00 |
$18,857,000 |
442,656 |
3.24% |
5,026,000 |
-10,083 |
0.341 |
N/A |
|
UTHR |
United Therapeutics Corp |
12 |
- |
$295.22 |
$18,159,000 |
58,907 |
3.12% |
10,044,000 |
35,907 |
0.125 |
Drug Manufacturers - ... |
|
SBTX |
Silverback Therapeutics, Inc. |
13 |
New |
$0.00 |
$16,519,000 |
1,313,104 |
2.84% |
16,519,000 |
1,313,104 |
0.758 |
N/A |
|
CMPX |
Compass Therapeutics Ord Shs |
14 |
- |
$0.00 |
$16,041,000 |
8,442,783 |
2.76% |
3,618,000 |
-125,113 |
6.106 |
N/A |
|
JANX |
Janux Therapeutics, Inc. |
15 |
- |
$0.00 |
$15,314,000 |
567,193 |
2.63% |
3,000,000 |
337,193 |
1.087 |
N/A |
|
RARE |
Ultragenyx Pharmaceutical Inc |
16 |
- |
$39.46 |
$14,428,000 |
398,445 |
2.48% |
-2,022,000 |
7,427 |
0.433 |
Restaurants |
|
MLTX |
Multisys Language Solutions... |
17 |
- |
$0.00 |
$12,348,000 |
316,049 |
2.12% |
-4,722,000 |
819 |
0.503 |
N/A |
|
WVE |
Wave Life Sciences Ltd. |
18 |
- |
$6.75 |
$12,197,000 |
1,509,580 |
2.1% |
-6,225,000 |
20,343 |
1.267 |
N/A |
|
RVMD |
Revolution Medicines, Inc. |
19 |
- |
$37.19 |
$11,212,000 |
317,083 |
1.93% |
-2,514,000 |
3,266 |
0.187 |
N/A |
|
ALKS |
Alkermes Plc |
20 |
New |
$29.00 |
$11,148,000 |
337,603 |
1.92% |
11,148,000 |
337,603 |
0.184 |
Drug Delivery |
|
OLMA |
Olema Pharmaceuticals, Inc. |
21 |
- |
$0.00 |
$11,018,000 |
2,930,446 |
1.89% |
-5,962,000 |
17,896 |
4.877 |
N/A |
|
RCKT |
Rocket Pharmaceuticals |
22 |
- |
$2.88 |
$10,794,000 |
1,618,265 |
1.86% |
-2,034,000 |
597,706 |
1.747 |
N/A |
|
ITOS |
Iteos Therapeutics, Inc. |
23 |
- |
$0.00 |
$10,423,000 |
1,745,943 |
1.79% |
-2,986,000 |
0 |
4.599 |
N/A |
|
RNAC |
Cartesian Therapeutics, Inc |
24 |
- |
$11.37 |
$10,422,000 |
790,779 |
1.79% |
-2,494,000 |
69,640 |
4.444 |
N/A |
|
TWST |
Twist Bioscience Corp |
25 |
- |
$0.00 |
$10,255,000 |
261,215 |
1.76% |
-2,176,000 |
-6,282 |
0.376 |
N/A |
|
XENE |
Xenon Pharmaceuticals Inc. |
26 |
- |
$0.00 |
$10,179,000 |
303,398 |
1.75% |
2,448,000 |
106,186 |
0.403 |
N/A |
|
VERA |
Vera Therapeutics, Inc. |
27 |
- |
$0.00 |
$9,986,000 |
415,719 |
1.72% |
-916,000 |
157,931 |
0.758 |
N/A |
|
REPL |
Replimune Group Inc |
28 |
- |
$9.55 |
$9,624,000 |
987,036 |
1.65% |
-1,881,000 |
37,036 |
1.365 |
N/A |
|
IOVA |
Iovance Biotherapeutics Inc |
29 |
- |
$1.75 |
$9,020,000 |
2,708,582 |
1.55% |
-10,767,000 |
34,677 |
0.892 |
N/A |
|
CNTX |
Context Therapeutics Inc. |
30 |
- |
$0.00 |
$9,000,000 |
14,705,882 |
1.55% |
-6,441,000 |
0 |
19.608 |
N/A |
|
MBX |
Mbx Biosciences, Inc. |
31 |
New |
$0.00 |
$8,361,000 |
1,132,950 |
1.44% |
8,361,000 |
1,132,950 |
3.39 |
N/A |
|
NUVB |
Nuvation Bio Ord Shs Class A |
32 |
- |
$10.42 |
$8,188,000 |
4,652,243 |
1.41% |
-2,889,000 |
488,065 |
2.147 |
N/A |
|
ORIC |
Oric Pharmaceuticals, Inc. |
33 |
New |
$0.00 |
$7,809,000 |
1,399,514 |
1.34% |
7,809,000 |
1,399,514 |
1.984 |
N/A |
|
IDYA |
Ideaya Biosciences, Inc. |
34 |
- |
$0.00 |
$7,046,000 |
430,161 |
1.21% |
-3,595,000 |
16,126 |
0.441 |
N/A |
|
SLDB |
Solid Biosciences Inc |
35 |
- |
$4.87 |
$6,077,000 |
1,642,356 |
1.04% |
6,077,000 |
1,642,356 |
4.255 |
N/A |
|
RLAY |
Relay Therapeutics, Inc. |
36 |
- |
$3.60 |
$6,015,000 |
2,295,924 |
1.03% |
-3,333,000 |
27,099 |
1.375 |
N/A |
|
STOK |
Stoke Therapeutics, Inc. |
37 |
- |
$11.55 |
$4,615,000 |
693,988 |
0.79% |
-2,950,000 |
8,162 |
1.108 |
N/A |
|
VERU |
Veru Inc |
38 |
- |
$0.58 |
$3,231,000 |
6,592,727 |
0.56% |
443,000 |
2,307,362 |
9.437 |
Personal Products |
|
HOWL |
Werewolf Therapeutics, Inc. |
39 |
- |
$0.00 |
$2,341,000 |
2,408,810 |
0.4% |
-1,193,000 |
20,799 |
5.924 |
N/A |
|
DSGN |
Design Therapeutics, Inc. |
40 |
- |
$0.00 |
$2,173,000 |
562,943 |
0.37% |
-1,279,000 |
3,396 |
1.012 |
N/A |
|
ADAP |
Adaptimmune Therapeutics PLC |
41 |
- |
$0.24 |
$964,000 |
4,894,344 |
0.17% |
-1,783,000 |
-201,568 |
3.165 |
N/A |
|
RPTX |
Repare Therapeutics Inc. |
42 |
- |
$0.00 |
$808,000 |
819,924 |
0.14% |
-805,000 |
-411,230 |
2.231 |
N/A |
|
ALXO |
Alx Oncology Holdings Inc |
43 |
- |
$0.00 |
$343,000 |
550,000 |
0.06% |
-1,981,000 |
-841,434 |
1.104 |
N/A |
|
ARCT |
Arcturus Therapeutics Ltd |
46 |
Closed |
$6.94 |
$0 |
0 |
0% |
-7,805,000 |
-459,943 |
0 |
N/A |
|
STRO |
Sutro Biopharma Inc |
48 |
Closed |
$0.76 |
$0 |
0 |
0% |
-3,975,000 |
-2,160,062 |
0 |
N/A |
|
AQST |
Aquestive Therapeutics, Inc. |
45 |
Closed |
$3.68 |
$0 |
0 |
0% |
-5,738,000 |
-1,611,833 |
0 |
N/A |
|
MIRM |
Mirum Pharmaceuticals, Inc. |
53 |
Closed |
$0.00 |
$0 |
0 |
0% |
-24,379,000 |
-589,579 |
0 |
N/A |
|
INSM |
Insmed Inc |
44 |
Closed |
$98.24 |
$0 |
0 |
0% |
-26,899,000 |
-389,611 |
0 |
Biotechnology |
|
IRON |
Disc Medicine, Inc |
52 |
Closed |
$53.17 |
$0 |
0 |
0% |
-21,962,000 |
-346,401 |
0 |
N/A |
|
AKRO |
Akero Therapeutics, Inc. |
51 |
Closed |
$0.00 |
$0 |
0 |
0% |
-12,814,000 |
-460,617 |
0 |
N/A |
|
SRRK |
Scholar Rock Holding Corp |
50 |
Closed |
$35.55 |
$0 |
0 |
0% |
-17,986,000 |
-416,144 |
0 |
N/A |
|
AXSM |
Axsome Therapeutics, Inc. |
47 |
Closed |
$103.91 |
$0 |
0 |
0% |
-4,231,000 |
-50,000 |
0 |
N/A |
|
ZNTL |
Zentalis Pharmaceuticals, Llc |
49 |
Closed |
$1.24 |
$0 |
0 |
0% |
-3,354,000 |
-1,106,851 |
0 |
N/A |
|